| Literature DB >> 22474521 |
Jaung-Geng Lin1, Yuan-Yu Chan, Yi-Hung Chen.
Abstract
Acupuncture is an accepted treatment worldwide for various clinical conditions, and the effects of acupuncture on opiate addiction have been investigated in many clinical trials. The present review systematically analyzed data from randomized clinical trials published in Chinese and English since 1970. We found that the majority agreed on the efficacy of acupuncture as a strategy for the treatment of opiate addiction. However, some of the methods in several included trials have been criticized for their poor quality. This review summarizes the quality of the study design, the types of acupuncture applied, the commonly selected acupoints or sites of the body, the effectiveness of the treatment, and the possible mechanism underlying the effectiveness of acupuncture in these trials.Entities:
Year: 2012 PMID: 22474521 PMCID: PMC3296192 DOI: 10.1155/2012/739045
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Summary of studies included in the review.
| Author (year) | Jadad score | No. of subjects (acup/control) | Mean age (male%) | Inclusion criteria | Intervention type | Treatment frequency (duration) | Treated acupoints | Type of | Outcome measure | Results | Adverse events |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Washburn et al. (1993), [ | 1 | 100 (55/45) | (1) Standard treatment group: 40.5 (63%) | Self-reported with history of intravenous use of heroin confirmed by physical examination for signs of recent needle use | AA | Daily | Sympathetic | Nonspecific points | (1) Attendance rate | (1) | (1) Slight bleeding |
|
| |||||||||||
| Wells et al. (1995), [ | 3 | 60/(31/29) | (1) Specific group: — (54.8%) | Only subjects for whom opiates were determined to be the primary drug and who met federal requirements for entry into methadone treatment | AA | Phase I: 5 days per week | Sympathetic | Nonspecific points | (1) Attendance and retention rate | (1) NS | NR |
|
| |||||||||||
| Zhang et al. (2000), [ | 1 | 181 (121/60) | (1) Specific group: 27.1 (—) | (1) DSM III for opiate dependence | HANS (The frequency was 2/100 HZ; the intensities were 12–16 mA on arms and 16–26 mA on legs) | Phase I: 4 times per day | Hegu (LI4) | Electrodes were placed at the acupoints without any electrical stimulation | (1) Heart rate | All 8 indices improved significantly ( | NR |
|
| |||||||||||
| Montazeri et al. (2002), [ | 2 | 40 (20/20) | (1) Specific group: 32 (100%) | Self-reported with history of heroin or opium addiction less than 6 months | Body acupuncture with manual stimulation | Once per day for 3 days | Hegu (LI4) | ROD by naloxone | CINA | The acupuncture group had smaller increase in CINA score compared to control group ( | No adverse events |
|
| |||||||||||
| Wu et al. (2003), [ | 1 | 120 (30/30/30/30) | (1) Acupuncture group: — (—%) | (1) CCMD II-R and DSM III-R for: opiate dependence | Body acupuncture with manual stimulation | Phase I: Twice a day (3 days) | Sishencong (EX-HN1) | (1) Opium plus buprenorphine therapies | (1) Opiate withdrawal scale | (1) Acupuncture group showed significant improvement in withdrawal syndrome after the 6th day ( | Mild dry mouth |
|
| |||||||||||
| Wen et al. (2005), [ | 2 | 220 (111/109) | (1) Acupuncture group: | (1) DSM IV for opiate dependence | Body acupuncture with manual stimulation | Once a day (10 days) | Hegu (LI4) | Oral administration of lofexidine hydrochloride | (1) Withdrawal symptom | (1) Acupuncture group showed significant improvements in withdrawal syndrome before and after treatment ( | NR |
|
| |||||||||||
| Margolin et al. (2005), [ | 1 | 40 (20/20) | (1) Five-needle NADA protocol group: 43.1 (65%) | HIV-positive methadone-maintained patients | AA | 5 days per week | Sympathetic | Month 1: | (1) Retention rate | (1) NS | NR |
|
| |||||||||||
| Zeng et al. (2005), [ | 1 | 70 (35/35) | (1) Treatment group: | (1) DSM III-R for opiate dependence | Body acupuncture with manual stimulation | Once a day (10 days) | Baihui (GV20) | Methadone 10-day decrescendo therapy | Scores of daily withdrawal symptoms | Acupuncture group showed significant improvement in withdrawal symptoms on the 1st, 2nd, 4th, 6th, 7th, 8th, 9th, and 10th days ( | NR |
|
| |||||||||||
| Mu et al. (2005), [ | 2 | 120 (30/30/30/30) | (1) Acupuncture group I: | (1) ICD-10 for opiate dependence | Body acupuncture with electrical stimulation (The frequency was 5 Hz; the intensity was 5 mA) | 3 times a week (10 weeks) | (1) Acupuncture group I: Jiaji (EX-B2) | (1) Simulation group: ST36, SP6 without electrical stimulation | (1) Withdrawal symptom | In the treatment of 4, 8, 10 weeks, acupuncture groups I and II showed significantly decreased withdrawal syndrome, HAMA, and SDS ( | NR |
|
| |||||||||||
| Bearn et al. (2009), [ | 3 | 83 (48/34) | (1) Acupuncture group: 36.2 (73%) | DSM IV for opiate dependence | AA | Once a day on weekdays | Five points in the ear cartilage ridge area (acupoints not mentioned) | Application of oil to the ear followed by the attachment of 5 metal clips | (1) Withdrawal symptoms | (1) NS | NR |
Note. Code. NR: not reported; NS: not significant; AA: auricular acupuncture; HANS: Han's acupoint nerve stimulator; ROD: rapid opiate detoxification; CINA: clinical institute narcotic assessment; CCMD: Chinese Classification of Mental Disorders; DSM: The Diagnostic and Statistical Manual of Mental Disorders; ICD: International Statistical Classification of Diseases and Related Health Problems; VAS: visual analogue scale.
Figure 1Flow diagram showing the number of studies included and excluded from the systematic review.
Summary of main acupoints/sites selected in the reviewed studies.
| Acupoints/sites | Frequency of appearance ( | Percentage ( |
|---|---|---|
| Zusanli (ST36) | 7 | 31.82 |
| Sanyinjiao (SP6) | 6 | 27.27 |
| Hegu (LI4) | 6 | 27.27 |
| Neiguan (PC6) | 5 | 22.72 |
| Shenmen (HT7) | 3 | 13.64 |
| Laogone (PC8) | 3 | 13.64 |
| Sympathetic (ear) | 3 | 13.64 |
| Shenmen (ear) | 3 | 13.64 |
| Kidney (ear) | 3 | 13.64 |
| Lung (ear) | 3 | 13.64 |
| Liver (ear) | 2 | 9.09 |
| Waiguan (SJ5) | 2 | 9.09 |
| Baihui (GV20/DU20) | 2 | 9.09 |
| Dazhui (GV14/DU14) | 2 | 9.09 |
| Jiaji (EX-B2) | 1 | 4.55 |
| Shenshu (BL23) | 1 | 4.55 |
| Sishencong (EX-HN1) | 1 | 4.55 |
| Taichong (LR3) | 1 | 4.55 |
| Shendao (GV11) | 1 | 4.55 |
| Lingtai (GV10) | 1 | 4.55 |
| Zhiyang (GV9) | 1 | 4.55 |
| Mingmen (GV4) | 1 | 4.55 |
Note. The sum was 22 for the percentage calculation.
Methodological quality scores.
| Washburn et al. [ | Wells et al. [ | Zhang et al. [ | Montazeri et al. [ | Wu | Wen et al. [ | Margolin et al. [ | Zeng et al. [ | Mu | Bearn et al. [ | |
|---|---|---|---|---|---|---|---|---|---|---|
| (1) Was the study described as randomized? | V | V | V | V | V | V | V | V | V | V |
| (2) Was the randomization scheme described and appropriate? | x | V | x | V | x | V | x | x | V | V |
| (3) Was the study described as double-blind? | x | x | x | x | x | x | x | x | x | x |
| (4) Was the method of double-blinding appropriate? | x | x | x | x | x | x | x | x | x | x |
| (5) Was there a description of dropouts and withdrawals? | x | V | x | x | x | x | x | x | x | V |
|
| ||||||||||
| Results | 1 | 3 | 1 | 2 | 1 | 2 | 1 | 1 | 2 | 3 |
V: yes = 1; x: no = 0; low quality, 0–2; high quality, 3–5.